ArticleCancer medicine2026
Lack of De-Intensification Models for Female Head and Neck Cancer Patients With Favorable Prognosis.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe prognostic relevance of gender in head and neck cancer is often neglected. In contrast, the more favorable prognosis of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) is well recognized, and de-escalation strategies are increasingly being tested in clinical trials. In this study, we focused on the prognostic significance of gender to clarify whether it should be given more attention. PATIENTS AND
methodsWe requested data on patients with newly diagnosed head and neck cancer between 2002 and 2017 from the German Center of Cancer Registry (n = 212,920). First, we focused on sex-specific survival according to primary tumor site in a nationwide context. Second, we examined a local dataset of 462 OPSCC patients, diagnosed at the University Hospitals of Ulm and Lübeck between 2005 and 2018 and followed up until 2024. Here we compared the prognostic value of sex with HPV status, alcohol consumption, and smoking habits (these parameters were not available at national level).
resultsIn the nationwide analysis, women showed better survival in all head and neck primary tumor sites studied. The mean survival difference was greatest in patients with OPSCC (1.3 years; p < 0.0001), followed by patients with nasopharyngeal carcinoma (1 year; p < 0.0001). In the subgroup of patients younger than the median age (62.8 years), women lived on mean 1.2 times longer than men (p < 0.0001). Besides, in the local dataset, men with HPV-positive OPSCC did not have a better prognosis than women, even when HPV-negative (p = 0.426). However, the prognostic effect of female sex may be attenuated in patients with high tobacco use; in this scenario, no sex-related difference in survival was found (p = 0.56).
conclusionSex-specific differences in survival, especially in OPSCC and nasopharyngeal cancers, suggest the implementation of gender-sensitive oncology regarding prevention, treatment, and aftercare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.